» Articles » PMID: 9826453

Race and Clinical Outcome in Patients with Carcinoma of the Uterine Cervix Treated with Radiation Therapy

Overview
Journal Gynecol Oncol
Date 1998 Nov 25
PMID 9826453
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of this study was to examine factors underlying differences in outcome between African-American (AA) and Caucasian (C) patients undergoing radiation therapy (RT).

Methods: Patient, tumor, treatment characteristics, and the outcome of 316 AA and 94 C cervical cancer patients who underwent RT were compared. Median follow-up was 72.4 months.

Results: AA patients had a trend to a poorer 8-year cause-specific survival (47.9 vs 60.6%) (P = 0.10) compared to C patients with a significant difference seen in stage IIB-IVA disease (34.3 vs 59.5%) (P = 0.04). Several factors correlated with poor outcome were present in the AA group including lower mean hemoglobin levels during RT (P = 0.001), lower median income (P = 0.001), and less frequent intracavitary RT (P = 0.09). In addition, while uncommon in C patients, health problems were major reasons for treatment protraction and inability to undergo intracavitary RT in the AA patients. Multivariate analysis demonstrated that race was not an independent prognostic factor after controlling for difference in patient, tumor, and treatment factors.

Conclusions: AA cervical cancer patients possess multiple factors that adversely impact upon the efficacy of RT. These findings may add further insight into the observed differences in outcome of cervical cancer patients based on race.

Citing Articles

Barriers to the Completion of Radiation Therapy in Cervical Cancer Treatment in Nigeria: A Review of Socioeconomic, Geographical, and Psychosocial Factors.

Adebisi A, Onobun D, Orji C, Ononye R Cureus. 2024; 16(10):e70747.

PMID: 39493197 PMC: 11530964. DOI: 10.7759/cureus.70747.


Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with Cervical Cancer: A Model-Based Period Analysis.

Fan X, He W, Zhang Q, Zhang B, Dong L, Li L Cancer Control. 2024; 31:10732748241232324.

PMID: 38408865 PMC: 10898299. DOI: 10.1177/10732748241232324.


A Bayesian network predicting survival of cervical cancer patients-Based on surveillance, epidemiology, and end results.

Liu G, Yang Z, Wang D Cancer Sci. 2022; 114(3):1131-1141.

PMID: 36285478 PMC: 9986069. DOI: 10.1111/cas.15624.


Healthcare Disparities in Gynecologic Oncology.

Grubbs A, Barber E, Roque D Adv Oncol. 2022; 2(1):119-128.

PMID: 35669851 PMC: 9165691. DOI: 10.1016/j.yao.2022.02.003.


Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.

Boyce-Fappiano D, Nguyen K, Gjyshi O, Manzar G, Abana C, Klopp A JCO Oncol Pract. 2021; 17(12):e1958-e1967.

PMID: 34550749 PMC: 8678033. DOI: 10.1200/OP.21.00291.